Connect your AI

Ventas VTR Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Healthpeak PropertiesDOC

$97K+51.6%

WelltowerWELL

$1.54B-22.5%

National Health InvestorsNHI

$0-100%

LTC PropertiesLTC

$43.41M+412%

Omega Healthcare InvestorsOHI

$104.88M-59.8%

Sonida Senior LivingSNDA

$108.78M—

Other financials

Income statement

Revenue$1.7B+22.0%

Net income$59.0M+22.1%

EPS (diluted)$0.11+10.0%

Balance sheet

Cash & equivalents$183.6M+0.7%

Total debt$12.7B-1.5%

Total equity$13.1B+14.4%

Total assets$27.7B+6.4%

Cash flow

Operating cash flow$394.6M+22.9%

Valuation

Market cap$43.17B+57.4%

Enterprise value$55.71B+39.5%

P/E158.6×+21.1×

P/S7×+1.9×

Profitability

Net margin4.4%+1.5pp

FCF margin33.1%—

Returns & leverage

Return on equity2.2%+0.8pp

Debt / equity1×-0.2×

Where this comes from

Reported directly by Ventas in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: Ventas’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ventas's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Ventas's stock issuance proceeds?: Ventas (VTR) reported stock issuance proceeds of $799.3M in Q1 2026.
How has Ventas's stock issuance proceeds changed year-over-year?: Ventas's stock issuance proceeds decreased by 8.8% year-over-year, from $876.46M to $799.3M.
What is the long-term trend for Ventas's stock issuance proceeds?: Over 4 years (2021 to 2025), Ventas's stock issuance proceeds has grown at a 39.6% compound annual growth rate (CAGR), from $617.44M to $2.34B.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.